- Home
- TCBX vs VSTM Comparison
TCBX vs VSTM Comparison
Compare TCBX & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- VSTM
- Stock Information
- Founded
- TCBX 2008
- VSTM 2010
- Country
- TCBX United States
- VSTM United States
- Employees
- TCBX N/A
- VSTM N/A
- Industry
- TCBX Banks
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- VSTM Health Care
- Exchange
- TCBX Nasdaq
- VSTM Nasdaq
- Market Cap
- TCBX 454.9M
- VSTM 425.9M
- IPO Year
- TCBX 2021
- VSTM 2012
- Fundamental
- Price
- TCBX $31.31
- VSTM $5.90
- Analyst Decision
- TCBX Hold
- VSTM Strong Buy
- Analyst Count
- TCBX 4
- VSTM 9
- Target Price
- TCBX $33.67
- VSTM $13.63
- AVG Volume (30 Days)
- TCBX 49.7K
- VSTM 2.7M
- Earning Date
- TCBX 07-23-2025
- VSTM 05-13-2025
- Dividend Yield
- TCBX N/A
- VSTM N/A
- EPS Growth
- TCBX 44.43
- VSTM N/A
- EPS
- TCBX 2.95
- VSTM N/A
- Revenue
- TCBX $172,270,000.00
- VSTM $10,000,000.00
- Revenue This Year
- TCBX $17.44
- VSTM $106.87
- Revenue Next Year
- TCBX $6.46
- VSTM $312.95
- P/E Ratio
- TCBX $10.42
- VSTM N/A
- Revenue Growth
- TCBX 17.40
- VSTM N/A
- 52 Week Low
- TCBX $18.82
- VSTM $2.10
- 52 Week High
- TCBX $39.45
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- TCBX 52.85
- VSTM 38.11
- Support Level
- TCBX $30.31
- VSTM $7.60
- Resistance Level
- TCBX $32.07
- VSTM $7.88
- Average True Range (ATR)
- TCBX 0.87
- VSTM 0.87
- MACD
- TCBX -0.04
- VSTM -0.23
- Stochastic Oscillator
- TCBX 47.07
- VSTM 5.19
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.